Key points are not available for this paper at this time.
Unresolved questions on repeated AAA screening, cost-effectiveness, and harms persist; leaves open need for updated RCTs before practice change.
A review focused on following key questions: Does AAA screening reduce AAA related mortality? For Induviduals who have no AAA on initial screening, does periodic repeated screening reduce AAA-related adverse outcome? What is the cpst effectiveness of screening? Are there any parameter identifying population at high risk for AAA? What are the harms associated with elective repair of AAA?
No takes yet. Share an insight, caveat, or question.
Palombo et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: